Cagrilintide — 10 mg

Cagrilintide is a long-acting amylin analog studied for its role in appetite regulation, satiety, and weight management. It mimics the effects of the natural hormone amylin, which complements GLP-1 activity to support metabolic balance and sustained fat-loss research.

Benefits

• Appetite regulation — studied for reducing hunger and promoting satiety.
• Weight management — explored for sustained reductions in body weight in preclinical and clinical studies.
• Metabolic synergy — often researched in combination with GLP-1 analogs (e.g., Semaglutide, Retatrutide).
• Glucose stability — supports balanced insulin and glucose signaling.
• Extended activity — long half-life enables once-weekly research protocols.

What researchers look at

• Mechanism: amylin receptor agonism enhancing satiety and slowing gastric emptying.
• Combination potential with GLP-1 analogs for additive metabolic benefits.
• Human trials showing significant fat loss and appetite control.
• Exploration of energy expenditure and metabolic adaptation effects.

Quick Specs

• Form: Lyophilized peptide
• Net per vial: 10 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

Identity Basics

• Sequence: Ac-[25–37]-Human amylin analog with substitutions for extended activity
• Formula / M.W.: Approx. C₁₇₃H₂₇₃N₅₁O₅₃S, ~3900 g/mol
• CAS: 2138946-77-8

⚠️ Disclaimer

• This product is intended for laboratory research use only.

• Not for human or veterinary use.

• Not approved for diagnostic, therapeutic, or medical applications.

• Handle using appropriate laboratory safety procedures and personal protective equipment.